Literature DB >> 33835761

CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.

Chao Li1, Eleanor Brant2, Hikmet Budak3, Baohong Zhang4.   

Abstract

Since it was first recognized in bacteria and archaea as a mechanism for innate viral immunity in the early 2010s, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) has rapidly been developed into a robust, multifunctional genome editing tool with many uses. Following the discovery of the initial CRISPR/Cas-based system, the technology has been advanced to facilitate a multitude of different functions. These include development as a base editor, prime editor, epigenetic editor, and CRISPR interference (CRISPRi) and CRISPR activator (CRISPRa) gene regulators. It can also be used for chromatin and RNA targeting and imaging. Its applications have proved revolutionary across numerous biological fields, especially in biomedical and agricultural improvement. As a diagnostic tool, CRISPR has been developed to aid the detection and screening of both human and plant diseases, and has even been applied during the current coronavirus disease 2019 (COVID-19) pandemic. CRISPR/Cas is also being trialed as a new form of gene therapy for treating various human diseases, including cancers, and has aided drug development. In terms of agricultural breeding, precise targeting of biological pathways via CRISPR/Cas has been key to regulating molecular biosynthesis and allowing modification of proteins, starch, oil, and other functional components for crop improvement. Adding to this, CRISPR/Cas has been shown capable of significantly enhancing both plant tolerance to environmental stresses and overall crop yield via the targeting of various agronomically important gene regulators. Looking to the future, increasing the efficiency and precision of CRISPR/Cas delivery systems and limiting off-target activity are two major challenges for wider application of the technology. This review provides an in-depth overview of current CRISPR development, including the advantages and disadvantages of the technology, recent applications, and future considerations.

Entities:  

Keywords:  Cancer; Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas); Coronavirus disease 2019 (COVID-19); Crop improvement; Gene knock-out/in; Gene repair/replacement; Genome editing; Precision breeding

Year:  2021        PMID: 33835761     DOI: 10.1631/jzus.B2100009

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  28 in total

1.  New vision on the new era of genome study.

Authors:  Parwinder Kaur; Baohong Zhang
Journal:  Funct Integr Genomics       Date:  2022-02       Impact factor: 3.410

2.  Efficient gene editing in a medaka (Oryzias latipes) cell line and embryos by SpCas9/tRNA-gRNA.

Authors:  Qihua Pan; Junzhi Luo; Yuewen Jiang; Zhi Wang; Ke Lu; Tiansheng Chen
Journal:  J Zhejiang Univ Sci B       Date:  2022-01-15       Impact factor: 3.066

3.  A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system.

Authors:  Xinyi Li; Bing Sun; Hongrun Qian; Jinrong Ma; Magdalena Paolino; Zhiying Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

4.  Functional characterization of piggyBac-like elements from Nilaparvata lugens (Stål) (Hemiptera: Delphacidae).

Authors:  Jun Lyu; Qin Su; Jinhui Liu; Lin Chen; Jiawei Sun; Wenqing Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2022-06-15       Impact factor: 5.552

Review 5.  Genetic Engineering Approaches for Enhanced Insect Pest Resistance in Sugarcane.

Authors:  Aneela Iqbal; Raham Sher Khan; Mubarak Ali Khan; Karim Gul; Fazal Jalil; Daud Ali Shah; Hazir Rahman; Talaat Ahmed
Journal:  Mol Biotechnol       Date:  2021-04-24       Impact factor: 2.695

Review 6.  Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.

Authors:  Alesya G Bykonya; Alexander V Lavrov; Svetlana A Smirnikhina
Journal:  Mol Biotechnol       Date:  2022-03-24       Impact factor: 2.695

Review 7.  Synthetic Biology in Plants, a Boon for Coming Decades.

Authors:  Dipinte Gupta; Gauri Sharma; Pooja Saraswat; Rajiv Ranjan
Journal:  Mol Biotechnol       Date:  2021-08-21       Impact factor: 2.695

8.  A single transcript CRISPR/Cas9 mediated mutagenesis of CaERF28 confers anthracnose resistance in chilli pepper (Capsicum annuum L.).

Authors:  Rukmini Mishra; Jatindra Nath Mohanty; Bijayalaxmi Mahanty; Raj Kumar Joshi
Journal:  Planta       Date:  2021-06-16       Impact factor: 4.116

9.  Response of Root Growth and Development to Nitrogen and Potassium Deficiency as well as microRNA-Mediated Mechanism in Peanut (Arachis hypogaea L.).

Authors:  Lijie Li; Qian Li; Kyle E Davis; Caitlin Patterson; Sando Oo; Wanying Liu; Jia Liu; Guo Wang; Julia Elise Fontana; Thomas Elliott Thornburg; Isaac Seth Pratt; Fei Li; Zhiyong Zhang; Yanzhong Zhou; Xiaoping Pan; Baohong Zhang
Journal:  Front Plant Sci       Date:  2021-06-11       Impact factor: 5.753

10.  Functional Validation of cas9/guideRNA Constructs for Site-Directed Mutagenesis of Triticale ABA8'OH1 loci.

Authors:  Krzysztof Michalski; Christian Hertig; Dariusz R Mańkowski; Jochen Kumlehn; Janusz Zimny; Anna M Linkiewicz
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.